MhpB is a non-heme iron-dependent extradiol dioxygenase that catalyzes the oxidative ring cleavage of catecholic intermediates, such as 2,3-dihydroxyphenylpropionate (DHPP) and 2,3-dihydroxicinnamic acid (DHCI), during the degradation of aromatic compounds like 3-phenylpropionic acid (PP) and cinnamic acid (CI) . While native to E. coli, recombinant expression in other organisms (including potential P. luminescens systems) could leverage its catalytic versatility for biodegradation applications.
The 2.59 Å resolution cryoEM structure of MhpB (PDB ID: 9kti) reveals a decameric assembly with a catalytic chamber positioned at the side of the structure. Key features include:
Iron-binding site: A non-heme Fe(II) coordinated by conserved residues (e.g., His-115, His-179, and Asp-114).
Substrate-binding pocket: Hydrophobic residues that accommodate aromatic catechol derivatives .
MhpB shares 58% sequence identity with the Alcaligenes eutrophus MpcI enzyme and forms a distinct class of extradiol dioxygenases. Conserved histidines in the N-terminal domain are critical for catalysis .
MhpB employs a non-heme iron-dependent mechanism involving:
Substrate coordination: Catechol binds to Fe(II), enabling oxidative cleavage.
Lactone formation: A Criegee intermediate forms via radical recombination .
Ring fission: Hydrolysis of the lactone yields aliphatic dicarboxylic acids (e.g., 3-ketoadipic acid) .
His-115 → Gln: Abolishes catalytic activity (loss of base).
His-179 → Gln: Disrupts lactone hydrolysis (acidic group required).
Asp-114 → Ala: Reduces activity at high pH (impacts metal chelation) .
MhpB operates in convergent pathways for phenylpropanoid degradation:
PP pathway:
CI pathway:
| Pathway | Substrate | Intermediate | Product |
|---|---|---|---|
| PP degradation | 3-Phenylpropionic acid | DHPP | 3-Ketoadipic acid |
| CI degradation | Cinnamic acid | DHCI | 3-Ketoadipic acid |
MhpB’s ability to degrade aromatic pollutants (e.g., catechols, cinnamic acid derivatives) positions it for use in:
Environmental remediation: Breaking down persistent aromatic contaminants .
Industrial bioengineering: Modulating substrate preference via site-directed mutagenesis (e.g., enhancing DHCI specificity) .
Enhance biocontrol efficacy: By degrading plant-derived aromatic compounds in the rhizosphere .
Expand metabolic versatility: Leveraging MhpB for aromatic compound catabolism in agricultural settings .
Recombinant expression: No studies document MhpB expression in P. luminescens.
Synergistic systems: Combining MhpB with P. luminescens’ secondary metabolites (e.g., antibiotics) for dual-use applications.
Structural optimization: Engineering MhpB for improved stability or substrate range using cryoEM-derived insights .
This enzyme catalyzes the non-heme iron(II)-dependent oxidative cleavage of 2,3-dihydroxyphenylpropionic acid and 2,3-dihydroxicinnamic acid, yielding 2-hydroxy-6-ketononadienedioate and 2-hydroxy-6-ketononatrienedioate, respectively.
KEGG: plu:plu2208
STRING: 243265.plu2208